Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models.

Bonsi P, Ponterio G, Vanni V, Tassone A, Sciamanna G, Migliarini S, Martella G, Meringolo M, Dehay B, Doudnikoff E, Zachariou V, Goodchild RE, Mercuri NB, D'Amelio M, Pasqualetti M, Bezard E, Pisani A.

EMBO Mol Med. 2019 Jan;11(1). pii: e9283. doi: 10.15252/emmm.201809283.

2.

Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia.

Bastide MF, Glangetas C, Doudnikoff E, Li Q, Bourdenx M, Fernagut PO, Dumont ÉC, Georges F, Bézard E.

Sci Rep. 2017 May 24;7(1):2348. doi: 10.1038/s41598-017-02572-9.

3.

CD154 Induces Matrix Metalloproteinase-9 Secretion in Human Podocytes.

Rigothier C, Daculsi R, Lepreux S, Auguste P, Villeneuve J, Dewitte A, Doudnikoff E, Saleem M, Bourget C, Combe C, Ripoche J.

J Cell Biochem. 2016 Dec;117(12):2737-2747. doi: 10.1002/jcb.25571. Epub 2016 May 5.

PMID:
27070919
4.

D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly.

Barroso-Chinea P, Thiolat ML, Bido S, Martinez A, Doudnikoff E, Baufreton J, Bourdenx M, Bloch B, Bezard E, Martin-Negrier ML.

Neurobiol Dis. 2015 Jun;78:77-87. doi: 10.1016/j.nbd.2015.02.024. Epub 2015 Mar 10.

PMID:
25766677
5.

Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia.

Bastide MF, de la Crompe B, Doudnikoff E, Fernagut PO, Gross CE, Mallet N, Boraud T, Bézard E.

Biol Psychiatry. 2016 Mar 1;79(5):345-353. doi: 10.1016/j.biopsych.2014.08.022. Epub 2014 Sep 9.

PMID:
25442003
6.

Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?

Charron G, Doudnikoff E, Canron MH, Li Q, Véga C, Marais S, Baufreton J, Vital A, Oliet SH, Bezard E.

Front Aging Neurosci. 2014 Sep 24;6:258. doi: 10.3389/fnagi.2014.00258. eCollection 2014.

7.

Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.

Engeln M, Bastide MF, Toulmé E, Dehay B, Bourdenx M, Doudnikoff E, Li Q, Gross CE, Boué-Grabot E, Pisani A, Bezard E, Fernagut PO.

Biol Psychiatry. 2016 Mar 1;79(5):354-361. doi: 10.1016/j.biopsych.2014.07.007. Epub 2014 Jul 15.

PMID:
25146322
8.

Single-molecule imaging of the functional crosstalk between surface NMDA and dopamine D1 receptors.

Ladepeche L, Dupuis JP, Bouchet D, Doudnikoff E, Yang L, Campagne Y, Bézard E, Hosy E, Groc L.

Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):18005-10. doi: 10.1073/pnas.1310145110. Epub 2013 Oct 14.

9.

D1 dopamine receptor-mediated LTP at GABA synapses encodes motivation to self-administer cocaine in rats.

Krawczyk M, Mason X, DeBacker J, Sharma R, Normandeau CP, Hawken ER, Di Prospero C, Chiang C, Martinez A, Jones AA, Doudnikoff É, Caille S, Bézard E, Georges F, Dumont ÉC.

J Neurosci. 2013 Jul 17;33(29):11960-71. doi: 10.1523/JNEUROSCI.1784-13.2013.

10.

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking.

Porras G, Berthet A, Dehay B, Li Q, Ladepeche L, Normand E, Dovero S, Martinez A, Doudnikoff E, Martin-Négrier ML, Chuan Q, Bloch B, Choquet D, Boué-Grabot E, Groc L, Bezard E.

J Clin Invest. 2012 Nov;122(11):3977-89. doi: 10.1172/JCI59426. Epub 2012 Oct 8.

11.

Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.

Dehay B, Ramirez A, Martinez-Vicente M, Perier C, Canron MH, Doudnikoff E, Vital A, Vila M, Klein C, Bezard E.

Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9611-6. doi: 10.1073/pnas.1112368109. Epub 2012 May 30.

12.

Endogenous morphine-like compound immunoreactivity increases in parkinsonism.

Charron G, Doudnikoff E, Laux A, Berthet A, Porras G, Canron MH, Barroso-Chinea P, Li Q, Qin C, Nosten-Bertrand M, Giros B, Delalande F, Van Dorsselaer A, Vital A, Goumon Y, Bezard E.

Brain. 2011 Aug;134(Pt 8):2321-38. doi: 10.1093/brain/awr166. Epub 2011 Jul 8.

PMID:
21742735
13.

Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease.

Ahmed MR, Berthet A, Bychkov E, Porras G, Li Q, Bioulac BH, Carl YT, Bloch B, Kook S, Aubert I, Dovero S, Doudnikoff E, Gurevich VV, Gurevich EV, Bezard E.

Sci Transl Med. 2010 Apr 21;2(28):28ra28. doi: 10.1126/scitranslmed.3000664.

14.

Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia.

Berthet A, Porras G, Doudnikoff E, Stark H, Cador M, Bezard E, Bloch B.

J Neurosci. 2009 Apr 15;29(15):4829-35. doi: 10.1523/JNEUROSCI.5884-08.2009.

15.

Cytoplasmic expression of human telomerase catalytic protein (hTERT) in neutrophils: an immunoelectron microscopy study.

Lepreux S, Doudnikoff E, Aubert I, Bioulac-Sage P, Bloch B, Martin-Negrier ML.

Ultrastruct Pathol. 2008 Sep-Oct;32(5):178-83. doi: 10.1080/01913120802034504.

PMID:
18958789
16.

Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia.

Schuster S, Doudnikoff E, Rylander D, Berthet A, Aubert I, Ittrich C, Bloch B, Cenci MA, Surmeier DJ, Hengerer B, Bezard E.

Biol Psychiatry. 2009 Mar 15;65(6):518-26. doi: 10.1016/j.biopsych.2008.09.008. Epub 2008 Oct 23.

PMID:
18947822
17.

Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure.

Scholz B, Svensson M, Alm H, Sköld K, Fälth M, Kultima K, Guigoni C, Doudnikoff E, Li Q, Crossman AR, Bezard E, Andrén PE.

PLoS One. 2008 Feb 13;3(2):e1589. doi: 10.1371/journal.pone.0001589.

18.

Differences in ultrastructural localization of dopaminergic D1 receptors between dorsal striatum and nucleus accumbens in the rat.

Dumartin B, Doudnikoff E, Gonon F, Bloch B.

Neurosci Lett. 2007 Jun 4;419(3):273-7. Epub 2007 Apr 21.

PMID:
17498877
19.

Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.

Guigoni C, Doudnikoff E, Li Q, Bloch B, Bezard E.

Neurobiol Dis. 2007 May;26(2):452-63. Epub 2007 Feb 9.

PMID:
17350277
20.

Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.

Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmoulière A.

Int J Biochem Cell Biol. 2006 Feb;38(2):135-51. Epub 2005 Sep 23. Review.

PMID:
16257564
21.

Aging and subcellular localization of m2 muscarinic autoreceptor in basalocortical neurons in vivo.

Décossas M, Doudnikoff E, Bloch B, Bernard V.

Neurobiol Aging. 2005 Jul;26(7):1061-72. Epub 2004 Nov 23.

PMID:
15748786

Supplemental Content

Loading ...
Support Center